HORMONE REPLACEMENT THERAPY AND RISK FOR BREAST CANCER
- 9 June 1997
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 26 (2) , 361-378
- https://doi.org/10.1016/s0889-8529(05)70252-8
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Heterogeneity of the Effect of Family History on Breast Cancer RiskEpidemiology, 1991
- MAMMOGRAPHIC PARENCHYMAL PATTERNS IN WOMEN RECEIVING NONCONTRACEPTNE ESTROGEN TREATMENTAmerican Journal of Epidemiology, 1989
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPYAmerican Journal of Epidemiology, 1989
- Menstrual Factors and Risk of Breast CancerCancer Investigation, 1988
- Menopausal oestrogens and breast cancer risk: An expanded case-control studyBritish Journal of Cancer, 1986
- ESTROGEN RECEPTORS IN BREAST CANCER ASSOCIATION WITH EPIDEMIOLOGIC RISK FACTORSAmerican Journal of Epidemiology, 1986
- Menopausal estrogen use and risk of breast cancerCancer, 1981
- The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patternsCancer, 1980
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896